Clinical Trial Update: Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors [EARLY_Phase 1]

View source ↗

Summary

Early-phase 1 clinical trial update for nelfinavir in gammaherpesvirus-related tumors, noting termination of the study despite investigation in multiple lymphom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castleman Disease
• Epstein-barr Virus Infection
• Gastric Cancer
• Hodgkin Lymphoma
• Kaposi Sarcoma
• Nasopharyngeal Cancer
• Non-hodgkin Lymphoma

Drugs mentioned

• Nelfinavir (nelfinavir)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Non-Hodgkin Lymphoma, Hodgkin Lymphoma | EARLY_Phase 1 | Status: TERMINATED